1.Lui A, Do T, Alzayat O, Yu N, Phyu S, Santuya HJ, Liang B, Kailash V, Liu D, Inslicht SS, Shahlaie K, Liu DZ. Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders.Pharmaceuticals,2024 Mar 27;17(4):426.PMID:38675388
2.Ye Z,Izadi A, Gurkoff GG,RickerlK, Sharp FR, Ander BP,BauerAZ, Lui A, Lyeth BG, LiuDZ. Combined Inhibition of Fyn and c-Src Protects Hippocampal Neurons and Improves Spatial Memory via ROCK after Traumatic Brain Injury.J Neurotrauma.2022 Apr;39(7-8):520-529.PMID:35109711
3.LiuDZ,Lyeth B.Martin R, Shahlaie K.Methods (of Using Abemaciclib)for Treating Brain Injury.(Patent：US2022/051931)
4.LiuDZ,Lyeth B.Martin R, Shahlaie K.Methods (of Using Dasatinib)for Treating Brain Injury.(Patent：US2022/051052)
5.Liu DZ.Methods (of MicroRNA Therapy) for Treating Brain Injury. (Patent：US2019/ 019235)
6.Lv B, Cheng XY, Sharp FR, Ander BP,Liu DZ.Broad therapeutic window of miR-122 mimic to improve stroke outcome through indirect inhibition of NOS2.Front. Neurosci. 2018;12:767.PMID: 30405345
7.Liu DZ,Ander BP, Cell Cycle Inhibition without Disruption of Neurogenesis is a Strategy for Treatment of Aberrant Cell Cycle Diseases: an Update.ScientificWorldJournal. 2012; 2012:491737.PMID: 22547985
